Shouxiangu(603896.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Shouxiangu
603896.SH
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand.
229.44 B
603896.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
D
Personal Care ProductsIndustry
Industry Ranking27/28
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE-0.50%D
    • Profit Margin-1.85%D
    • Gross Margin76.97%A
  • Growth ScoreD
    • Revenue YoY-2.54%D
    • Net Profit YoY-107.41%E
    • Total Assets YoY3.30%C
    • Net Assets YoY-2.65%D
  • Cash ScoreE
    • Cash Flow Margin-1629.89%E
    • OCF YoY-2.54%D
  • Operating ScoreD
    • Turnover0.2D
  • Debt ScoreB
    • Gearing Ratio28.82%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Tmall Health has joined dozens of brands to establish the "Health Supplement Assurance Alliance"

    36Kr·
    SH
    600572
    -1.64%
    SH
    603896
    -1.64%
    SH
    600664
    -3.10%
    36Kr·
    SH
    600572
    -1.64%
    SH
    603896
    -1.64%
    SH
    600664
    -3.10%

    Shouxiangu released its performance for the first three quarters, with a net profit attributable to the parent company of 76.34 million yuan, a year-on-year decrease of 33.47%

    Zhitong·
    SH
    603896
    -1.64%
    Zhitong·
    SH
    603896
    -1.64%

    Shouxiangu: Subsidiary "Shouxiangu Brand Ganoderma Spore Oil Soft Capsules" product completes re-registration as a domestic health food

    Zhitong·
    SH
    603896
    -1.64%
    Zhitong·
    SH
    603896
    -1.64%

    Shouxiangu: 2025 Shareholder Return Program Launch

    Zhitong·
    SH
    603896
    -1.64%
    Zhitong·
    SH
    603896
    -1.64%

    Shouxiangu: Net profit of 65.5586 million yuan in the first half of 2025, a year-on-year decrease of 33.99%

    Zhitong·
    SH
    603896
    -1.64%
    Zhitong·
    SH
    603896
    -1.64%
    © 2026 Longbridge｜Disclaimer